Ketamine, originally developed as a dissociative anesthetic in the 1960s, remains a valuable medication in controlled medical settings for anesthesia, acute pain management, and increasingly for treatment-resistant depression via esketamine nasal spray. However, non-medical ketamine exposure—recreational use, self-administration outside clinical supervision, or obtaining diverted pharmaceutical supplies—carries a wide spectrum of serious health risks. These dangers […]